Showing results (1981-1990 of 2,234) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|January 31, 2012
Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiationJames W Hodge, Hadley J Sharp, Sofia R GameiroCancer Biotherapy & Radiopharmaceuticals|November 19, 2014
Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivoIrene Tsiapa, George Loudos, Eirini A Fragogeorgi, et al.Cancer Biotherapy & Radiopharmaceuticals|February 24, 2001
Ferrocenes (F168, F169) and fero-sorbitol-citrate (FSC): potential anticancer drugsA Ferle-Vidović, M Poljak-Blazi, V Rapić, et al.Cancer Biotherapy & Radiopharmaceuticals|February 24, 2001
Recurrent ovarian clear cell carcinoma: complete remission after radiation in combination with hyperthermia; a case study and in vitro studyM Suzuki, Y Saga, S Tsukagoshi, et al.Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study resultsP L Weiden, H B Breitz, O Press, et al.Cancer Biotherapy & Radiopharmaceuticals|March 31, 2000
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node stagingA Spanu, G Dettori, P Chiaramida, et al.Cancer Biotherapy & Radiopharmaceuticals|August 15, 2000
Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probeG Mariani, G Villa, M Gipponi, et al.Cancer Biotherapy & Radiopharmaceuticals|August 15, 2000
Effect of cisplatin-based chemotherapy on emergence of cisplatin resistance, and its correlation with intracellular glutathione levels and accumulation of p53 protein in human ovarian cancerA S Juvekar, M K Adwankar, H B TongaonkarCancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Capromab Pendetide imaging of prostate cancerM K Haseman, S A Rosenthal, T J PolascikCancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Review: the application of dendritic cell-derived exosomes in tumour immunotherapyB Quah, H C O'NeillPageof 224